Kriegel and Watson to Present During AUTM 2015 Business Development Course – Medical Devices

November 18, 2015
Dallas, TX

Marshall, Gerstein & Borun attorneys Jeremy R. Kriegel and Julie M. Watson will present courses during the 2015 Association of University Technology Managers (AUTM) Business Development Course – Medical Devices, which takes place from November 17-18, 2015 in Dallas, TX. The course is designed to provide detailed insights into the medical device market and the pre-clinical, clinical, regulatory, business, marketing and legal issues technology transfer professionals encounter when licensing to the medical device industry. For the full course schedule, click here.

Tuesday, Nov. 17 at 1:00 p.m.: "Overview of Medical Device Market and Technology Transfer Experience"

  • Julie Watson, Marshall, Gerstein & Borun LLP
  • Alan R. Bentley, Vanderbilt University
  • James Kemler, Stryker Corp.
  • Axel Strombergsson, Vanderbilt University

The panelists will describe the medical device market broadly, and will explore market opportunities and growth segments for new generations of devices. Programs for de-risking medical device commercial opportunities are discussed, together with policy implications of such translational research. An assessment of the impact regulatory expertise in academia will be explored. When to out-license and how to structure transactions for different classes of devices will be reviewed. This session will conclude with a report on medical device deal structures based on data from the AUTM TransACT database.

Wednesday, Nov. 18 at 1:15 p.m.: "Legal Issues"

  • Jeremy Kriegel, Marshall, Gerstein & Borun LLP
  • Robert Wanerman, Epstein Becker Green

In this session, two attorneys with extensive regulatory and compliance experience will address a wide range of topics affecting technology transfer, including:

  • Evaluating medical device disclosures for potential patent eligibility problems
  • Issues and strategies for significant foreign jurisdictions
  • Compliance issues arising under National Institutes of Health (NIH) and National Science Foundation (NSF) grant laws and policies
  • Fraud and abuse risks
  • Coordinating technology transfer into the university’s compliance program

Learn more about Marshall Gerstein’s speakers:

Jeremy R. Kriegel is listed in Chambers USA as a "key individual" at Marshall, Gerstein & Borun. Chambers 2013 praises the "thorough[ness] in his consideration of the issues and their potential impact on his client’s business," and his "innovative insight and creative solutions." Chambers 2012 says he "is known for his work in medical device patents. He is well-respected by his peers for his expertise in patent prosecution." Mr. Kriegel reliably guides clients in such industries as medical devices and consumer products, and across all phases of the product life-cycle. His clients find he readily grasps complex IP rights and business issues, building from his training in mechanical engineering. Mr. Kriegel is the prosecution practice chair for Marshall Gerstein and has drafted and prosecuted numerous medical device-related patent applications on behalf of universities.

Julie M. Watson concentrates on counseling related to intellectual property transactions with a particular emphasis on technology startups and university technology transfers. As a licensing professional with over 25 years of experience structuring complex intellectual property transactions in-house, Ms. Watson has a deep appreciation of clients' needs and knows how to deliver strategic solutions.